Regulatory & Legal

The diagnostics firm posts strong 2025 growth, but the impending loss of a key partner puts its high-stakes strategic pivot squarely to the test.

IM Cannabis has 180 days to raise its stock price above $1.00 or risk delisting from Nasdaq, highlighting broader struggles in the global cannabis sector.

Sellers returned to the Mid-Atlantic housing market in March, but rising rates and global conflict are creating an uneven and unpredictable spring season.

Gartner's new Adversarial Exposure Validation category signals a major shift in cybersecurity. Find out how AI-driven platforms like Hadrian are leading the way.

A new state-backed tool lets Nevadans compare hospital costs, but providers warn of unintended consequences. Is this the future of healthcare transparency?

Landmark trial shows proton therapy boosts survival and cuts side effects, offering new hope as cancer rates climb in adults under 50.

A group known for challenging pandemic rules will now advise on US vaccine policy. Can it rebuild trust, or will it deepen the medical divide?

As the tax deadline nears, experts warn of illegal 'ghost preparers' who vanish after filing fraudulent returns, leaving taxpayers to face the IRS alone.

Following a $600M all-stock acquisition, security firm Concorde International embraces a new identity, YOOV, signaling a bold pivot into AI.

South Korea's Miracell has secured FDA clearance for its SMART M-CELL system, challenging established players in the booming U.S. regenerative medicine market.

The Chinese EV maker released landmark ESG and climate reports, boosting transparency as it navigates tough regulations and mixed investor sentiment.

A new study shows the feasibility of a single device for glucose monitoring and insulin delivery, aiming to simplify life for millions with diabetes.

As NW Natural Holdings sets its Q1 2026 earnings call, investors watch to see if its diversification strategy can sustain last year's record growth.

Ceva Animal Health appoints former Virbac CEO Sébastien Huron as Deputy CEO, creating a dual leadership aimed at accelerating growth and operational might.

Selkirk Copper secures C$20M to restart the Minto Mine, a landmark project majority-owned by the Selkirk First Nation, aiming to supply critical copper.

An initial $3.9 billion commitment to the Global Environment Facility signals a united front for nature, but is it enough to meet ambitious 2030 goals?

Solaris Resources unlocks $50M in funding with a key environmental nod for its Warintza copper project, but unresolved Indigenous opposition looms large.

A new natural suppository aims to break the cycle of recurrent yeast infections by supporting the vaginal microbiome, offering hope to millions of women.

A landmark partnership is tokenizing not just gold bars, but the very output of U.S. mines, offering investors a direct stake in physical production.

Backed by FDA approval and strong clinical data, EBR Systems' leadless WiSE pacer is set to transform cardiac therapy for previously untreatable patients.